References
Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Spanu T, Ambretti S, Ginocchio F, Cristini F, Losito AR, Tedeschi S, Cauda R, Bassetti M (2012) Predictors of mortality in bloodstream infections caused by KPC-producing Klebsiella pneumoniae: importance of combination therapy. Clin Infect Dis 55:943–950
Timsit JF, Perner A, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Doig GS, Herridge M, Jaber S, Joannidis M, Papazian L, Peters MJ, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Citerio G, Azoulay E (2015) Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics. Intensive Care Med 41:575–588
Tascini C, Sbrana F, Flammini S, Tagliaferri E, Arena F, Leonildi A, Ciullo I, Amadori F, Di Paolo A, Ripoli A, Lewis R, Rossolini GM, Menichetti F, GENGUT Study Group (2014) Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: relevance of concomitant systemic antibiotic therapy. Antimicrob Agents Chemother 58:1972–1976
Urbani L, Masi G, Puccini M, Colombatto P, Vivaldi C, Balestri R, Marioni A, Prosperi V, Forfori F, Licitra G, Leoni C, Paolicchi A, Boraschi P, Lunardi A, Tascini C, Castagna M, Buccianti P (2015) Minor-but-complex liver resection: an alternative to major resections for colorectal liver metastases involving the hepato-caval confluence. Medicine (Baltimore) 94:e1188
Capone A, Giannella M, Fortini D, Giordano A, Meledandri M, Ballardini M, Venditti M, Bordi E, Capozzi D, Balice MP, Tarasi A, Parisi G, Lappa A, Carattoli A, Petrosillo N, SEERBIO-GRAB network (2013) High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect 19:E23–E30
Acknowledgments
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
In the past 2 years, C.T. has been paid for lectures on behalf of Pfizer, Novartis, Merck, Angelini, Gilead, and Astellas. No conflict of interest for the other authors.
Funding
No financial support was received.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tascini, C., Urbani, L., Sbrana, F. et al. Oral administration of gentamicin for prophylaxis of KPC-producing Klebsiella pneumoniae gut colonization in patients treated with a novel parenchymal-sparing liver surgery: the GEN Gut study. Intensive Care Med 42, 124–125 (2016). https://doi.org/10.1007/s00134-015-4049-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-015-4049-x